HFSA 2026: ATTRibute-CM Analysis; LINK-HF2 Results; More

New science presented at HFSA 2026 and simultaneously published in JACC: Heart Failure spans several evolving areas in heart failure (HF), from ATTR-CM biomarkers and measures of physical function to predictors of adverse outcomes in transplant recipients to artificial intelligence (AI) wearables enhancing discharge care following HF hospitalization.

ACC-Supported Radiation Safety Coalition Seeks Clinician Input

The ACC and the ALARA+ Coalition are seeking input from cardiovascular clinicians and health care facility administrators to help better understand the real-world impacts of occupational radiation exposure and inform future workplace safety efforts.

ACCEL Lite: TRANQUILITY: IL-6, An Important Mediator of CVD

In this episode, Dipti Itchhaporia MD, MACC and Deepak L. Bhatt, MD, MPH, MBA, FACC discuss TRANQUILITY: Efficacy of monthly and quarterly dosing of pacibekitug (IL-6 ligand mAb) targeting inflammation in CKD with high cardiovascular risk.

Sports Cardiology Research and Guideline Highlights: Early 2026

The 2026 ESC/ACC clinical consensus statement on Masters Athletes With Abnormal Cardiovascular Findings is guided by a clinical consensus statement outlining expert recommendations for the diagnostic assessment, management, and risk stratification of cardiac abnormalities in masters athletes (MAs).